Growth hormone and the heart

Mineral and Electrolyte Metabolism

Volumn 25, Issue 1-2, 1999, Pages 51-55

  Cittadini, Antonio ^a   Longobardi, Salvatore ^a   Fazio, Serafino ^a   Saccà, Luigi ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Department of Internal Medicine ^*  (Italy)

Author keywords

Growth hormone; Heart; Insulin like growth factor 1

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN;

ARTICLE; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; PRIORITY JOURNAL; VASCULAR RESISTANCE;

ANIMALS; CARDIAC OUTPUT, LOW; GROWTH HORMONE; HEART; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I;

EID: 0032891265     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057420     Document Type: Article

References (39)

1. De Boer H, Blok GJ, Van der Veen E: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995;16:63-86.
2. Castagnino HE, Toranzos FA, Milei J, Weiss V, Beigelman R, Sarchi MI, Bordenave CA, Azcoaga R: Preservation of the myocardial collagen framework by human growth hormone in experimental infarction and reduction in the incidence of ventricular aneurysms. Int J Cardiol 1992;35:101-114.
3. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJS: Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526-534.
4. Timsit J, Riou B, Bertherat J, Wisnewsky C, Kato NS, Weisberg AS, Lubetzki J, Lecarpentier Y, Winegrad S, Mercadier JJ: Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetic, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest 1990;86:507-515.
5. Jin H, Yang R, Gillet N, Clark R, Ko A, Paoni NF: Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats with chronic ACE inhibition. J Cardiovasc Pharmacol 1995;26:420-425.
6. Duerr RL, McKirnan D, Gim RD, Clark R, Chien KR, Ross J Jr: Cardiovascular effects of insulin-like growth factor 1 and growth hormone in chronic left ventricular failure in the rat. Circulation 1996;93:2188-2196.
7. Cittadini A, Grossman JD, Napoli R, Katz SE, Stromer H, Smith RJ, Clark R, Morgan JP, Douglas PS: Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol 1997;29:1109-1116.
8. Fazio S, Biondi B, Sabatini D, Cuocolo A, Tommaselli AP, Lombardi G, Saccà L: Long-term growth hormone deficiency as a cause of cardiomyopathy and its reversibility with specific replacement therapy. J Clin Endocrinol Metab 1996;81:887-890.
9. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, Saccà L: A preliminary study of growth hormone in the treatment of heart failure in patients with dilated cardiomyopathy. N Engl J Med 1996; 334:809-814.
10. Volterrani M, Desenzani P, Lorusso R, D'Aloia A, Manelli F, Giustina A: Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet 1997;349:1067-1068.
11. Capaldo B, Patti L, Oliviero U, Longobardi S, Pardo F, Vitale F, Fazio S, Di Rella F, Biondi B, Lombardi G, Saccà L: Increased arterial intimamedia thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 1997; 82:1378-1381.
12. Mathews LS, Enberg B, Norstedt G: Regulation of rat growth hormone receptor gene expression. J Biol Chem 1989;17:9905-9910.
13. Engelmann GL, Bohem KD, Haskell JF, Khairallah PA, Ilan J: Insulin-like growth factors and neonatal cardiomyocyte development: Ventricular gene expression and membrane receptor variations in normotensive and hypertensive rats. Mol Cell Endocrinol 1989;63:1-14.
14. Guler HP, Zapf J, Scheiwiller E, Froesch ER: Recombinant human insulin-like growth factor 1 stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988;85:4889-4893.
15. D'Ercole AJ, Stiles AD, Underwood LE: Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad SCi USA 1984;81:935-939.
16. Cittadini A, Strömer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS: Differential cardiac effects of growth hormone and IGF-1 in the rat: A combined in vivo and in vitro evaluation. Circulation 1996;93:800-809.
17. Ito H, Hiroe M, Hirata Y, Motoyoshy T, Adachi S, Masayoshi S, Koike A, Nogami A, Marumo F: Insulin-like growth factor-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation 1993;87:1715-1721.
18. Cittadini A, Strömer H, Vatner DE, Grossman JD, Katz ES, Clark R, Morgan JP, Douglas PS: Consequences of GH deficiency on cardiac structure, function, and β-adrenergic pathway: Studies in mutant dwarf rats. Endocrinology 1997;138:5161-5169.
19. Fazio S, Cittadini A, Sabatini D, Merola B, Colao AM, Biondi B, Lombardi G, Saccà L: Evidence for biventricular involvement in acromegaly: A Doppler echocardiographic study. Eur Heart J 1993;14:26-33.
20. Fazio S, Cittadini A, Cuocolo A, Merola B, Sabatini D, Nicolai E, Colao AM, Biondi B, Lombardi G, Saccà L: Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab 1994;79: 441-446.
21. Merola B, Cittadini A, Colao A, Ferone D, Fazio S, Sabatini D, Biondi B, Saccà L, Lombardi G: Chronic treatment with octreotide improves cardiac abnormalities in patients with acromegaly. J Clin Endocrinol Metab 1993;77:790-793.
22. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Saccà L, Bellastella A: Body composition, bone metabolism, heart structure and function in growth hormone-deficient adults before and after growth hormone replacement therapy at low doses. J Clin Endocrinol Metab 1993;77: 1671-1676.
23. Strömer H, Cittadini A, Douglas PS, Morgan JP: Exogenously administered growth hormone and IGF-1 alter intracellular calcium handling and enhance cardiac performance: In vitro evaluation in the isolated isovolumic buffer perfused rat heart. Circ Res 1996;79:227-236.
24. Cittadini A, Spindler M, Stromer H, Ishguro Y, Travers KE, Ingwall JS, Morgan JP: Mechanism of the IGF-1-positive inotropic action (abstract). J Am Coll Cardiol 1997;29:404A.
25. Stromer H, Cittadini A, Grossman JD, Morgan JP: Normal cardiac function requires growth hormone (abstract). Circulation 1996;94:1-421.
26. Fazio S, Cittadini A, Sabatini D, Merola B, Colao A, Biondi B, Longobardi S, Lombardi G, Saccà L: Growth hormone and heart performance: A novel mechanism of cardiac wall stress regulation in humans. Eur Heart J 1997;18:340-347.
27. Fryburg DA, Gelfand RA, Barrett JB: Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 1991;260:E499-E504.
28. Fryburg DA: Insulin-like growth factor-1 exerts growth hormone and insulin-like actions on human muscle protein. Am J Physiol 1994;267: E331-E336.
29. Wu HY, Yue CL, Chyu KY, Hsueh WA, Chan TM: Endothelial-dependent vascular effects of insulin-like factor 1 in the perfused rat mesenteric artery and aortic ring. Diabetes 1994;43: 1027-1032.
30. Haylor J, Singh I, El Nahas AM: Nitric oxide inhibitor prevents vasodilatation by insulin-like growth factor 1. Kidney Int 1991;39:333-335.
31. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS: Direct demonstration of insulin-like factor-1-induced nitric oxide production by endothelial cells. Kidney Int 1994; 45:598-604.
32. Cuneo RC, Wilmshurst P, Lowy C, McGauley G, Sonksen PH: Cardiac failure responding to growth hormone. Lancet 1989;i:838-839.
33. Frustaci A, Perrone GA, Gentiloni N, Russo MA: Reversible dilated cardiomyopathy due to growth hormone deficiency. Am J Clin Pathol 1992;97:503-511.
34. Sütsch G, Donath M, Yan XW, Brunner HP, Follath F, Froesch ER, Kiowski W: Beneficial hemodynamic effects of acute IGF-1 in patients with chronic heart failure (abstract). J Am Coll Cardiol 1997;29:285A.
35. O'Driscoll JG, Green DJ, Ireland M, Kerr D, Larbalestier RI: Treatment of end-stage cardiac failure with growth hormone. Lancet 1997;349: 1068.
36. Osterziel KL, Strohm O, Schuler J, Friedrich M, Hänlein D, Willenbrock R, Anker SD, Poole-Wilson PA, Ranke MB, Dietz R: Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998;351:1233-1237.
37. Cittadini A, Ishiguro Y, Strömer H, Spindler M, Moses AC, Clark R, Douglas PS, Ingwall JS, Morgan JP: Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitising the myofilaments to calcium through a wortmannin-sensitive pathway: Studies in rat and ferret isolated muscles. Circ Res 1998;83:50-59.
38. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM: Cardioprotective effect of insulin-like growth factor 1 in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 1995;92:8031-8035.
39. Giustina A, Lorusso R, Borghetti V, Bugari G, Misitano V, Alfieri O: Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy. Am Heart J 1996;131:620-622.